Skip to main content
VANI
NASDAQ Life Sciences

Vivani Medical Cleared to Start Phase 1 Trial for Semaglutide Implant in Obesity

Tom Rudovsky · Reported by GlobeNewswire
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$1.24
Mkt Cap
$105.207M
52W Low
$0.923
52W High
$1.92
52W Position info
34% above low
Off High info
35% below high
Rel. Volume info
0.9× avg
Market data snapshot near publication time

VANI sits 34% above its 52-week low of $0.923.

Summary

Vivani Medical has received regulatory approval to initiate SLIM-1, a Phase 1 clinical trial for its NPM-139 semaglutide implant in obesity. This is a significant step for the clinical-stage biotech, moving its lead GLP-1 candidate into human trials for a major indication. The news builds on the successful first-in-human trial results for NPM-139 reported on June 4th and follows substantial insider stock purchases by a director in recent months, indicating strong confidence. The SLIM-1 trial will primarily assess safety, tolerability, and pharmacokinetics, with weight loss as a secondary endpoint. Successful results could pave the way for a dose-ranging efficacy trial (SLIM-2).

At the time of this announcement, VANI was trading at $1.24 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $105.2M. The 52-week trading range was $0.92 to $1.92. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: GlobeNewswire.


Price Chart

Share this article

Copied!

VANI - Latest Insights

VANI
Nov 12, 2026, 8:00 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.18
Real-time Price: $1.13 info
Change: -$0.0518 (-4%) info
Market Cap: $101.93M info
VANI
Nov 12, 2026, 8:00 AM EST
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $1.17
Real-time Price: $1.13 info
Change: -$0.040 (-3%) info
Market Cap: $101.93M info
VANI
Nov 11, 2026, 4:05 PM EST
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.13
Real-time Price: $1.13 info
Change: $0 (0%) info
Market Cap: $101.93M info
VANI
Aug 13, 2026, 4:01 PM EDT
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.34
Real-time Price: $1.13 info
Change: -$0.210 (-16%) info
Market Cap: $101.93M info
VANI
Aug 06, 2026, 8:15 AM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.40
Real-time Price: $1.13 info
Change: -$0.270 (-19%) info
Market Cap: $101.93M info